Clinical Trial Update: Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 1/2a trial to evaluate the safety and immunogenicity of the StreptInCor vaccine candidate for rheumatic heart di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatic Heart Disease

Drugs mentioned

• StreptInCor (StreptInCor vaccine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Rheumatic Heart Disease, Rheumatic Heart Disease in Children | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING